GLOBALISATION AND PHARMACEUTICAL INDUSTRIES IN NIGERIA: A STUDY OF ORIS UMOEZE NIG. LTD AND NIPRIPHARM LAB LTD IN ABUJA

dc.contributor.authorIBRAHIM, ABU AKOH
dc.date.accessioned2017-07-31T09:35:29Z
dc.date.available2017-07-31T09:35:29Z
dc.date.issued2016-08
dc.descriptionBeing a Dissertation submitted to the School of Post Graduate Studies, Ahmadu Bello University, Zaria. In Partial fulfillment of the requirements for the degree of Masters of Science in Political Science Department of Political Science and International Studies, Faculty of Social Sciences, Ahmadu Bello University, Zaria, Nigeriaen_US
dc.description.abstractThe world has become almost a single organism such that whatever happens to a part has its ripple effects on others. This study investigates the effects of globalization on Nigerian pharmaceutical industries with special focus on Oris Umoeze Nig. Ltd and Nipripharm Lab Ltd in Abuja. This was carried out to achieve the following objectives: To examine the nature of Nigerian pharmaceutical industries in this era of globalization. ii. To investigate the effects of globalization on Oris Umoeze Nigeria limited and Nipripharm Lab Limited. And finally, to examine the factors hindering Oris Umoeze Nigeria limited and Nipripharm Lab Ltd from achieving a global standard. The study used both primary and secondary data. The primary data were generated from questionnaire and interview while the secondary data were derived from journals, internet materials, unpublished materials and text books. A total of two hundred and thirty-three questionnaires were distributed to drug manufacturers, importers, wholesalers, retailers and patent drug vendors. Two hundred questionnaires were completed and returned representing 85.8 percent of the sampled population. Descriptive statistics via SPSS was employed in the analysis of the questionnaires. The data generated from the questionnaire was corroborated by the interviews and the secondary materials consulted. This was to ensure authenticity and internal validity. The research reveals that globalisation has encouraged free flow of pharmaceutical products which has brought stiff competition to the locally manufactured pharmaceutical products. This study was also able to establish that Oris Umoeze Nigeria Limited and Nipripharm Lab Limited do not employ state of the arts facilities in their production processes neither do they follow acceptable production process as such do not comply with the minimum standard set by WHO. Therefore, the medicines manufactured by these companies have not achieved WHO pre-qualification basically because of many domestic factors which are even worsened by the free flow of pharmaceutical products from countries around the world. In fact, no medicine by pharmaceutical manufacturing companies in the whole of West African Region has met with WHO Pre-qualification. Only few products of three Companies in the whole of Africa have attained WHO pre-qualification: a. Aspen Pharmacare Ltd. Port Elizabeth, Republic of South Africa.b. Maphar SA, Casablanca, Morocco and c. Quality Chemicals Industry Ltd, Kampala, Uganda. What this entails is that no pharmaceutical manufacturing company in Nigeria can be patronized by any international support Organizations such as the World Health Organization (WHO) or The European Union (EU).en_US
dc.identifier.urihttp://hdl.handle.net/123456789/9122
dc.language.isoenen_US
dc.subjectGLOBALISATION,en_US
dc.subjectORIS UMOEZE NIG. LTDen_US
dc.subjectPHARMACEUTICAL INDUSTRIES,
dc.subjectORIS UMOEZE NIG. LTD
dc.subjectNIPRIPHARM LAB LTD
dc.subjectABUJA
dc.titleGLOBALISATION AND PHARMACEUTICAL INDUSTRIES IN NIGERIA: A STUDY OF ORIS UMOEZE NIG. LTD AND NIPRIPHARM LAB LTD IN ABUJAen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
GLOBALISATION AND PHARMACEUTICAL INDUSTRIES IN NIGERIA A STUDY OF ORIS UMOEZE NIG. LTD AND NIPRIPHARM LAB LTD IN ABUJA.pdf
Size:
919.05 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections